Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SATELITE: Salvage Therapy in Granulomatosis With Polyangiitis
NCT04871191Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2025
- Primary completion
- Oct 2028
- Modality
- Antibody Conjugates, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of tocilizumab, tofacitinib oral solution in granulomatosis with polyangiitis (GPA), sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2025; status: recruiting.
02
Drugs
tocilizumabtofacitinib oral solution
03
Conditions
granulomatosis with polyangiitis (GPA)
Beyond the preview
Go deeper on NCT04871191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04871191.